Stokes, CS;
Goh, ET;
Vilstrup, H;
Morgan, MY;
Gluud, LL;
(2016)
L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy.
Cochrane Database of Systematic Reviews
, 2016
(10)
, Article CD012410. 10.1002/14651858.CD012410.
Preview |
Text
Morgan_Stokes_et_al-2016-The_Cochrane_Library.pdf - Published Version Download (273kB) | Preview |
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of L-ornithine L-aspartate versus placebo, no intervention, or other active interventions for people with cirrhosis and hepatic encephalopathy.




Archive Staff Only
![]() |
View Item |